Dear Friends,

I am pleased to welcome you to Hutchison MediPharma, an innovation driven pharmaceutical company located within the Zhangjiang High Tech Park of Shanghai, China.

At Hutchison MediPharma, we are dedicated to transforming scientific discoveries into advances in human healthcare to globally benefit mankind. All our efforts are directed towards discovering and developing innovative therapies for global markets, with focus on cancer and autoimmune diseases. We are pursuing this mission with passion, imagination, creativity and dedication.

Since the inception of the company in September 2002, Hutchison MediPharma has established a world class full-fledged R&D capability with cutting edge technology platforms and a rich portfolio of pipeline products in discovery and development stages. Our strategic alliances with leading global pharmaceutical companies not only further validates our R&D capabilities, but also brings both short-term revenue and long-term rewards. Hutchison MediPharma’s management team is recruited from major global pharmaceutical and biotech firms with many years of experience, bringing an exceptional level of R&D expertise to our firm. Based in Shanghai, China, Hutchison MediPharma is uniquely positioned to take advantage of a large pool of skilled local talent, a substantial native patient population, easy access to a booming biotech ecosystem, and an in-depth knowledge of a large spectrum of natural products. With the unwavering financial support and global business reputation of our ultimate parent company, Hutchison Whampoa, Hutchison MediPharma is poised to become a global leader in the biotechnology industry.

I want to thank you for your support and interest in Hutchison MediPharma, an emerging company that is transforming today’s science into tomorrow’s medicine.

Sincerely,

Samantha Du, Ph. D.

Founder and CEO